Genetically Predicted Adiposity, Diabetes, and Lifestyle Factors in Relation to Diverticular Disease
Overview
Authors
Affiliations
Background & Aims: Adiposity, type 2 diabetes, alcohol and coffee consumption, and smoking have been examined in relation to diverticular disease in observational studies. We conducted a Mendelian randomization study to assess the causality of these associations.
Methods: Independent genetic instruments associated with the studied exposures at genome-wide significance were obtained from published genome-wide association studies. Summary-level data for the exposure-associated single nucleotide polymorphisms with diverticular disease were available in the FinnGen consortium (10,978 cases and 149,001 noncases) and the UK Biobank study (12,662 cases and 348,532 noncases).
Results: Higher genetically predicted body mass index and genetic liability to type 2 diabetes and smoking initiation were associated with an increased risk of diverticular disease in meta-analyses of results from the two studies. The combined odds ratio of diverticular disease was 1.23 (95% confidence interval [CI], 1.14-1.33; P < .001) for a 1-standard deviation (~4.8 kg/m) increase in body mass index, 1.04 (95% CI, 1.01-1.07; P = .007) for a 1-unit increase in log-transformed odds ratio of type 2 diabetes, and 1.21 (95% CI, 1.12-1.30; P < .001) for a 1-standard deviation increase in prevalence of smoking initiation. Coffee consumption was not associated with diverticular disease, whereas the association for alcohol consumption largely differed between the 2 studies.
Conclusions: This study strengthens the causal associations of higher body mass index, type 2 diabetes, and smoking with an increased risk of diverticular disease. Coffee consumption is not associated with diverticular disease. Whether alcohol consumption affects the risk of diverticular disease needs further investigation.
Hashi R, Thamer R, Hassan A, Canna K, Ahmed M, Hassan M Geriatrics (Basel). 2025; 10(1).
PMID: 39997529 PMC: 11855509. DOI: 10.3390/geriatrics10010030.
Mendelian randomisation analysis for intestinal disease: achievement and future.
Ruan X, Che T, Chen X, Sun Y, Fu T, Yuan S eGastroenterology. 2025; 2(2):e100058.
PMID: 39944470 PMC: 11770446. DOI: 10.1136/egastro-2023-100058.
Ding H, Jiang Y, Sun Q, Song Y, Dong S, Xu Q Commun Biol. 2025; 8(1):47.
PMID: 39809838 PMC: 11733146. DOI: 10.1038/s42003-025-07481-6.
Tian W, Yang W, Wang X, Yang Y Food Sci Nutr. 2024; 12(12):10859-10866.
PMID: 39723082 PMC: 11666906. DOI: 10.1002/fsn3.4623.
Geng J, Ruan X, Wu X, Chen X, Fu T, Gill D Diabetes Obes Metab. 2024; 27(2):866-875.
PMID: 39592890 PMC: 7617254. DOI: 10.1111/dom.16087.